Zantac, a common heartburn drug, was ordered off of store shelves in 2020 nearly four decades after it was first approved by the FDA -U.S. Food and Drug Administration. Whether it was taken by prescription or over-the-counter, it contained an active ingredient called ranitidine. According to the FDA, the drug became contaminated with nitrosodimethylamine or (NDMA) which was found in samples of the product that had been stored for a prolonged period of time or at higher than recommended temperatures. The FDA lists NDMA as a probable human carcinogen, meaning it is likely to cause cancer. Zantac could therefore potentially result in an increased risk of the following five cancers: Bladder, Esophageal, Liver, Pancreatic, and of the Stomach.
One must have also taken Zantac (over the counter or prescription) for at least three months prior to the cancer diagnosis. The first Zantac trial started in October 2022 and is ongoing.
Accordingly, our firm shall continue to accept cases against the various companies that brought this dangerous product to the market. Unfortunately, unless you reside in the states of CA, IL, MA or VT, the generic brand cases are no longer being accepted as viable for the lawsuit.
If you have been diagnosed with one of the above cancers after using Zantac as referenced, seeking the advice of a qualified personal injury attorney who handles these mass tort matters is a good first step toward achieving fair compensation for your injuries.
Here at the Law Offices of Evan M. Ostfeld, we can even help obtain your medical records. Let us handle the ongoing litigation while you focus on your health! Call us at (866) BAD-RXRX (223-7979) for more information; we got your back!
